中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US11673933B2 Method for using insulin degludec for the improvement of glycemic control and reduction of acute and long-term diabetes complications 有权

  • Patent Title: Method for using insulin degludec for the improvement of glycemic control and reduction of acute and long-term diabetes complications
  • Application No.: US16463594
    Application Date: 2017-11-28
  • Publication No.: US11673933B2
    Publication Date: 2023-06-13
  • Inventor: Per Knud Christensen , Thue Johansen , Simon Skibsted , Kajsa Kvist
  • Applicant: Novo Nordisk A/S
  • Applicant Address: DK Bagsvaerd
  • Assignee: Novo Nordisk A/S
  • Current Assignee: Novo Nordisk A/S
  • Current Assignee Address: DK Bagsvaerd
  • Agent Rosemarie R. Wilk-Orescan
  • Priority: EP 200993 2016.11.28 EP 162803 2017.03.24 EP 174687 2017.06.07
  • International Application: PCT/EP2017/080603 2017.11.28
  • International Announcement: WO2018/096163A 2018.05.31
  • Date entered country: 2019-05-23
  • Main IPC: C07K14/62
  • IPC: C07K14/62 ;  A61P3/10 ;  A61K38/00
Method for using insulin degludec for the improvement of glycemic control and reduction of acute and long-term diabetes complications
Abstract:
The present invention relates to insulin degludec for use in medicine.
Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0